VOV.VN - Ambassador Dang Dinh Quy, permanent representative of Vietnam to the UN, has reaffirmed the nation’s support for the UN’s strategy aimed at promoting security and sustainable development in the African Great Lakes region.
Pretoria News, part of Independent Media - the leading South African media group, on April 7 published an article titled “Vietnam places hope in new leadership.”
VOV.VN - The nation has proactively fulfilled its dual role as a non-permanent member of the UN Security Council, whilst also affirming its role, prestige, position, and contributions to multilateral co-operation mechanisms as part of regional peacekeeping operations.
While there are several upside risks, moderating food prices should keep Vietnam’s inflation under control.
VOV.VN - The United Nations Mission in South Sudan (UNMISS) has played a vital role in recent times to promote political and security progress in South Sudan, according to Vietnamese Ambassador Dang Dinh Quy, permanent representative of Vietnam to the UN.
VOV.VN - The nation is becoming increasingly concerned about cases involving the use or threat of force in international relations, actions which run in contrast to the UN Charter and serve to harm international peace and security.
Building disease-free zones is the most important key to the sustainable development of the husbandry sector, Minister of Agriculture and Rural Development Nguyen Xuan Cuong said on February 23.
Vietnam imported more than 141,000 tonnes of pork worth US$334.4 million in 2020, representing a rise of 382% and 500% over the previous year, respectively, customs statistics showed.
Minister Counsellor Nguyen Phuong Tra, Deputy Permanent Representative of Vietnam to the UN, has urged relevant parties in the Central African Republic to resolve election-related differences through dialogue and negotiation, on the basis of respecting the country’s laws and Constitution.
VOV.VN - A vaccine developed by a Vietnamese company to combat the African swine fever (ASF) has proved effective following clinical trials and is expected to be commercially marketed in the second quarter of 2021.